DEA And FDA Highlight How Marijuana Is Safer Than Alcohol And Opioids During Rescheduling Hearing’s Opening Day
DEA and FDA lawyers presented testimony during the opening day of a federal hearing on the Trump administration's cannabis rescheduling proposal, highlighting evidence of marijuana's medical benefits and its relative safety compared to alcohol and opioids. The hearing proceeded without public livestreaming despite requests for transparency.
Filed under Federal Action in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of Terminally Ill Child Tells Congressional Committee
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
AOC Slams Federal Drug Laws That Restrict Marijuana And Psychedelics Despite Their Medical Value
Keith Ellison, 38 other attorneys general ask Congress to ban intoxicating hemp products
Trump puts medical cannabis protections in budget (Newsletter: April 6, 2026)
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Stay current on Minnesota cannabis
Browse more federal action updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.